| Mutant EZH2 induces a pre-malignant lymphoma niche by reprogramming the immune response W Béguelin, M Teater, C Meydan, KB Hoehn, JM Phillip, AA Soshnev, ... Cancer cell 37 (5), 655-673. e11, 2020 | 118 | 2020 |
| Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development MA Rivas, L Venturutti, YW Huang, R Schillaci, THM Huang, PV Elizalde Breast cancer research 14, 1-21, 2012 | 116 | 2012 |
| TNFα-induced mucin 4 expression elicits trastuzumab resistance in HER2-positive breast cancer MF Mercogliano, M De Martino, L Venturutti, MA Rivas, CJ Proietti, ... Clinical Cancer Research 23 (3), 636-648, 2017 | 109 | 2017 |
| MiR-16 mediates trastuzumab and lapatinib response in ErbB-2-positive breast and gastric cancer via its novel targets CCNJ and FUBP1 L Venturutti, RI Cordo Russo, MA Rivas, MF Mercogliano, F Izzo, ... Oncogene 35 (48), 6189-6202, 2016 | 86 | 2016 |
| TBL1XR1 mutations drive extranodal lymphoma by inducing a pro-tumorigenic memory fate L Venturutti, M Teater, A Zhai, A Chadburn, L Babiker, D Kim, W Béguelin, ... Cell 182 (2), 297-316. e27, 2020 | 82 | 2020 |
| Stat3 regulates ErbB-2 expression and co-opts ErbB-2 nuclear function to induce miR-21 expression, PDCD4 downregulation and breast cancer metastasis L Venturutti, LV Romero, AJ Urtreger, MF Chervo, RI Cordo Russo, ... Oncogene 35 (17), 2208-2222, 2016 | 75 | 2016 |
| Targeting ErbB-2 nuclear localization and function inhibits breast cancer growth and overcomes trastuzumab resistance RI Cordo Russo, W Beguelin, D Flaqué, CJ Proietti, L Venturutti, ... Oncogene 34 (26), 3413-3428, 2015 | 61 | 2015 |
| The dangers of déjà vu: memory B cells as the cells of origin of ABC-DLBCLs L Venturutti, AM Melnick Blood, The Journal of the American Society of Hematology 136 (20), 2263-2274, 2020 | 35 | 2020 |
| Invasive micropapillary carcinoma of the breast overexpresses MUC4 and is associated with poor outcome to adjuvant trastuzumab in HER2-positive breast cancer MF Mercogliano, G Inurrigarro, M De Martino, L Venturutti, MA Rivas, ... BMC cancer 17, 1-8, 2017 | 24 | 2017 |
| The role of the N-terminal tail for the oligomerization, folding and stability of human frataxin SE Faraj, L Venturutti, EA Roman, CB Marino-Buslje, A Mignone, ... FEBS Open Bio 3, 310-320, 2013 | 12 | 2013 |
| An aged/autoimmune B-cell program defines the early transformation of extranodal lymphomas L Venturutti, MA Rivas, BW Pelzer, R Flümann, J Hansen, I Karagiannidis, ... Cancer discovery 13 (1), 216-243, 2023 | 9 | 2023 |
| Nuclear PDCD4 expression defines a subset of luminal B-like breast cancers with good prognosis S Madera, MF Chervo, VA Chiauzzi, MG Pereyra, L Venturutti, F Izzo, ... Hormones and Cancer 11 (5), 218-239, 2020 | 9 | 2020 |
| The role of epigenetic mechanisms in B cell lymphoma pathogenesis L Venturutti, AM Melnick Annual Review of Cancer Biology 5 (1), 311-330, 2021 | 5 | 2021 |
| Profiling emergent behaviors from single-cell motility D Maity, P Kamat, N Zamponi, H Jayatilaka, A Giri, W Du, A Johnston, ... | 1 | 2022 |
| Nuclear PDCD4 Expression Predicts Good Clinical Outcome in Luminal A-Like and Luminal B-Like Breast Cancer Subtypes S Madera, VA Chiauzzi, MF Chervo, MG Pereyra, L Venturutti, ... Oxford Univ Press Inc, 2020 | | 2020 |
